Directorate Change

Chemring Group PLC
05 December 2024
 

FOR IMMEDIATE RELEASE                                                                                                    5 December 2024

 

CHEMRING GROUP PLC ("Chemring", the "Group" or the "Company")

 

Retirement of Non-Executive Director and Appointment of Senior Independent Director

 

Chemring announces that Andrew Davies, who has been a non-executive director since May 2016 and the Senior Independent Director since May 2020, will retire from the Board on 31 January 2025, having approached the end of his nine-year term, and will not therefore seek re-election at the 2025 Annual General Meeting. As previously indicated in the 2023 annual report, Fiona MacAulay, who has been a non-executive director since June 2020, will succeed Andrew as the Senior Independent Director.

 

Tony Wood, Chairman of Chemring, commented:

"On behalf of the Board I would like to thank Andrew for his invaluable guidance and commitment to the Group during his tenure on the Board. With his sector knowledge and experience, Andrew has made a significant contribution to the Board and the transformation of the Group during his tenure. We wish him well in the future."

 

There are no further disclosures required to be made in accordance with LR 9.6.13R of the Listing Rules of the UK Listing Authority.

 

 

For further information:

Rupert Pittman           Group Director of Corporate Affairs,                                     01794 463401

                                       Chemring Group PLC             

 

James McFarlane        MHP Group                                                                                 07584 142665

Ollie Hoare                                                                                                                         07817 458804

           

Cautionary statement

 

This announcement contains forward-looking statements that are based on current expectations or beliefs, as well as assumptions about future events. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts. Forward-looking statements often use words such as anticipate, target, expect, estimate, intend, plan, goal, believe, will, may, should, would, could, is confident, or other words of similar meaning. Undue reliance should not be placed on any such statements because they speak only as at the date of this document and, by their very nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results, and Chemring's plans and objectives, to differ materially from those expressed or implied in the forward-looking statements. There are a number of factors which could cause actual results to differ materially from those expressed or implied in forward-looking statements. Among the factors that could cause actual results to differ materially from those described in the forward-looking statements are: increased competition, the loss of or damage to one or more key customer relationships, changes to customer ordering patterns, delays in obtaining customer approvals for engineering or price level changes, the failure of one or more key suppliers, the outcome of business or industry restructuring, the outcome of any litigation, changes in economic conditions, currency fluctuations, changes in interest and tax rates, changes in raw material or energy market prices, changes in laws, regulations or regulatory policies, developments in legal or public policy doctrines, technological developments, the failure to retain key management, or the key timing and success of future acquisition opportunities or major investment projects. Chemring undertakes no obligation to revise or update any forward-looking statement contained within this announcement, regardless of whether those statements are affected as a result of new information, future events or otherwise, save as required by law and regulations.

 

Notes to editors

 

·   Chemring is a FTSE250 global business that specialises in the manufacture of high technology products and the provision of services to the aerospace, defence and security markets

·   Employing approximately 2,600 people worldwide, and with production facilities in four countries, Chemring meets the needs of customers in more than fifty countries

·   Chemring is organised under two strategic product segments: Sensors & Information and Countermeasures & Energetics

·   Chemring has a diverse portfolio of products that deliver high reliability solutions to protect people, platforms, missions and information against constantly changing threats

·   Operating in niche markets and with strong investment in research and development ("R&D"), Chemring has the agility to rapidly react to urgent customer needs

 

www.chemring.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings